Researchers from Hong Kong Baptist University (HKBU) and the Faculty of Medicine at The Chinese University of Hong Kong (CU Medicine) have jointly developed the Spermine Risk Score which, coupled with the use of a urine test, ...
Feb 8, 2021
0
6
An antidepressant in use for decades, repurposed to fight prostate cancer, shows promise in helping patients whose disease has returned following surgery or radiation, a pilot study at USC shows.
Mar 4, 2020
0
6
(HealthDay)—Men exposed to antidiabetic medications do not have different prostate-specific antigen (PSA) levels, and prostate cancer detection rates at biopsy do not differ regardless of trigger PSA levels, according to ...
Nov 7, 2019
0
2
PSA screening cuts deaths from prostate cancer by some 30 percent. This research was based on data of 20,000 men monitored for more than two decades. The men's initially measured PSA levels proved highly significant as a ...
Jan 23, 2019
0
3
Prostate cancer is the second most common cancer in American men. But black men bear a disproportionate burden of its effects. It's more common—and more than twice as deadly—among black men compared to their white counterparts. ...
Oct 2, 2018
0
2
University of Adelaide research shows that the results of the most widely used test for prostate cancer may be affected by obesity.
Jul 5, 2018
0
0
Men with non-metastatic castrate-resistant prostate cancer and a quickly rising PSA level present a medical dilemma. The rising PSA (prostate-specific antigen) means there is cancer activity, but no visible metastasis in ...
Jun 27, 2018
0
43
New research presented at this year's European Congress on Obesity (ECO) in Vienna, Austria (23-26) May shows that weight reduction following a sleeve gastrectomy (obesity surgery), which reduces the size of the stomach, ...
May 26, 2018
0
3
The biopsy shows cancer, so you have to act fast, right? Not necessarily, if it's a prostate tumor.
Jul 12, 2017
0
2
Patients with metastatic prostate cancer whose PSA levels remain high despite initial hormone treatments have historically had poor prognosis, with survival typically in the 1-2 year range. Results of a 40-person clinical ...
Apr 5, 2017
0
1
